Veröffentlichungen 2000
Publikationen
1. Brix G, Henze M, Doll J, Lucht R, Zaers J, Trojan H, Knopp MV, Haberkorn U. Diagnostik evaluation of the breast using PET: Optimization of data acquisition and postprocessing. Nuklearmed 2000;39:62-66.
2. Clorius JH, Schottler T, Haufe S, Zuna I, Reinbold F, Kaick G van. Afferent-efferent vessel dysfunction appears to be a specific characteristic of a large subset of patients with essential hypertension. American Journal of Hypertension 2000;13:332-339.
3. Deigner HP, Haberkorn U, Kinscherf R. Apoptosis modulators in the therapy of neurodegenerative diseases. Exp Opin Invest Drugs 2000;9:747-764.
4. Dimitrakopoulou-Strauss A, Strauss LG, Gutzler F, Rudi J. Parametric PET imaging in patients with hepatocellular carcinomas scheduled for percutaneous ethanol injection: Current and potential applications of C11Ethanol. Medical Imaging International 2000;10:6-11.
5. Eisenhut M, Haberkorn U. (123I)VIP receptor scintigraphy in patients with pancreatic adenocarcinomas. Eur J Nucl Med 2000;27:1589-1590.
6. Eisenhut M, Hull WH, Mohammed A, Mier W, Lay D, Just W, Gorgas K, Lehmann WD, Haberkorn U. Radioiodinated N-(2-Diethylaminoethyl)benzamide Derivatives with High Melanoma Uptake; Structure-Affinity Relationship Studies, Metabolic Fate and Intracellular Localisation J Med Chem 2000;43:3913-3922.
7. Haberkorn U. Neuentwicklungen und Perspektiven der PET. I Apoptose, Peptide, Gentherapie. Der Nuklearmediziner 2000;23:219-229.
8. Kahle B, Hoffend J, Hartschuh W, Petzoldt D. Ultrasound imaging of the sentinel lymph node in malignant melanoma. Hautarzt 2000;51:915-9.
9. Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Preparation and Evaluation of Tumor-Targeting Peptide-Oligonucleotide Conjugates. Bioconjugate Chemistry 2000;11:855-860.
10. Rohrschneider WK, Hoffend J, Becker K, Clorius JH, Darge K, Kooijman H, Troeger J. Combined static-dynamic MR urography for the simultaneous evaluation of morphology and function in urinary tract obstruction. I. Evaluation of the normal status in an animal model. Pediatr Radiol 2000;30(8):511-22.
11. Rohrschneider WK, Becker K, Hoffend J, Clorius JH, Darge K, Kooijman H, Troeger J. Combined static-dynamic MR urography for the simultaneous evaluation of morphology and function in urinary tract obstruction. II. Findings in experimen-tally induced ureteric stenosis. Pediatr Radiol 2000;30(8):523-32.
12. Schwarzbach M, Dimitrakopoulou-Strauss A, Willeke F, Hinz U, Strauss LG, Zhang YM, Mechtersheimer G, Attigah N, Lehnert T, Herfarth C. Clinical value of (18F) Fluordeoxyglucose Positron Emission Tomography imaging in soft tissue sarcomas. Ann Surg 2000;231(3):380-386.
13. Strauss LG (review). Sensitivity and specificity of positron emission tomography (PET) for the diagnosis of lymph node metastases. Recent Results Cancer Res 2000;157:12-19.
14. Wodarski C, Eisenbarth J, Weber K, Henze M, Haberkorn U, Eisenhut M. Synthesis of 3'-deoxy-3'-[18F]fluoro-thymidine with 2,3´-O-anhydro-5´-O-(4,4´-dimethoxytrityl) thymidine. J Labeled Compd Radiopharm 2000;43:1211-1218.
Buchbeiträge
1. Haberkorn U. Monitoring of gene therapy with PET. In; pp PET in clinical oncology. Wieler HJ, Coleman RE (ed.) Darmstadt 2000; pp 397-410.
2. Haberkorn U. Nuclear medicine and the monitoring of gene therapy. In: Molecular nuclear medicine with antibodies, peptides and nucleotides. Munz DL (ed.) Zuckschwerdt München 2000; pp 50-65.